| Name | Title | Contact Details |
|---|---|---|
Nina Hunter |
VP, Regulatory and Science | Profile |
Crystal Suri |
Executive Director, Intellectual Property | Profile |
Patrick Christmas |
Senior Vice President, General Counsel and Secretary | Profile |
Lisa Carlton |
Vice President, Global Regulatory Affairs | Profile |
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn`s disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention.
At ChemNavigator we help research organizations identify and procure the chemistry they need for drug discovery and agrochemical research. We serve researchers in medicinal, computational, and synthetic chemistry as well as chemical procurement
Santarus, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease.
BioScience Business Solutions is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.